# Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure

> **NCT01235403** · PHASE4 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 100 (actual)

## Conditions studied

- Partial Epilepsies

## Interventions

- **DRUG:** Lacosamide

## Key facts

- **NCT ID:** NCT01235403
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2018-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01235403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01235403, "Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01235403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*